Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-finding Phase I/II Trial of Daunorubicin and Cytarabine Combined to Fractionated Mylotarg® as Re-induction Treatment in Patients With First Relapse of Acute Myeloid Leukemia

NCT02182596 is registered in ClinicalTrials.gov with Acute Leukemia French Association as lead sponsor.

NCT NCT02182596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02182596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-finding Phase I/II Trial of Daunorubicin and Cytarabine Combined to Fractionated Mylotarg® as Re-induction Treatment in Patients With First Relapse of Acute Myeloid Leukemia
Lead sponsor
Acute Leukemia French Association
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2006
Completion date
January 31, 2011
Enrollment
20 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia